ATLANTA and CHICAGO, May 24, 2011 /PRNewswire/ -- For the fifth straight year, Elekta has
Elekta is among 12 providers chosen to present at the EHR Lab, a forum for ASCO members to discover the latest EHR technology. With nearly 30,000 members, ASCO is the world's leading professional organization representing physicians who care for people with cancer.
Elekta's integrated Oncology Information Systems features a complete, patient-centric chart optimized for medical oncology, radiation oncology and comprehensive practices. During the Lab, Elekta clinical experts will be available to provide hands-on demonstrations of MOSAIQ, and show how this unique, single-database EHR can perform clinical decision support, chemotherapy ordering and Quality Oncology Practice Initiative (QOPI®) case selection.
"Elekta has repeatedly demonstrated and followed through on its commitment to deliver a comprehensive and robust oncology-specific EHR and to support emerging healthcare trends," says Grant Spencer, Vice President, Product Creation, Oncology Information Systems. "For example, Elekta was a leader in support of government initiatives by offering the first comprehensive EHR to receive complete ONC-ATCB certification, and we were ready to implement ICD-10 diagnosis codes years ahead of the deadlines. Elekta is committed to the delegates of ASCO, our customers and clinical partners by providing efficient, streamlined workflows that allow them to focus on patient care."
To download a complimentary copy of Elekta's HITECH Act Action Plan, visit www.elekta.com/hitech. For the latest MOSAIQ news, stop by booth #16097 in the McCormick Place exhibit hall, or visit www.elekta.com/mosaiq.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible.
Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.
Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.
Subscribe to our Free Newsletters!
Breathing in unclean air due to increasing air pollution could cause kidney damage with resultant ...
Benign prostatic hyperplasia or enlarged prostate is a noncancerous condition observed in men above ...
Urinary retention is a condition where a person is unable to voluntarily empty the urinary bladder ...View All